Table 1 Baseline data of OCT data set
N | 92/92 (100.0%) | |
|---|---|---|
Age in years | 67.3 (±9.3) | |
Gender | Female | 13/92 (16.3%) |
Male | 77/92 (83.7%) | |
Cardiovascular risk factor | Smoker | 17/92 (18.5%) |
Hypercholesterolemia | 65/92 (70.7%) | |
Hypertension | 88/92 (95.7%) | |
Diabetes mellitus | 40/92 (43.5%) | |
Left ventricular function (ejection fraction) | Normal | 53/92 (57.6%) |
Mildly reduced | 20/92 (21.7%) | |
Reduced | 18/92 (19.6%) | |
Severely reduced | 1/92 (1.1%) | |
Coronary artery disease | One-vessel | 12/92 (13.0%) |
Two-vessel | 17/92 (18.5%) | |
Three-vessel | 63/92 (68.5%) | |
Clinical presentation | Stable angina | 53/92 (57.6%) |
Silent ischemia | 21/92 (22.8%) | |
Non-ST-Elevation myocardial infarction | 7/92 (7.6%) | |
Unstable angina | 10/92 (10.9%) | |
ST-Elevation myocardial infarction | 1/92 (1.1%) | |
Target vessel | Left anterior descending artery | 42/92 (45.7%) |
Left coronary artery | 2/92 (2.2%) | |
Left circumflex artery | 26/92 (31.5%) | |
Right coronary artery | 22/92 (23.9%) | |
Restenosis morphology | Complete occlusion | 3/92 (3.3%) |
Diffuse beyond stent | 1/92 (1.1%) | |
Diffuse intrastent | 25/92 (27.2%) | |
Focal body | 43/92 (46.7%) | |
Focal margin | 6/92 (6.5%) | |
Multifocal | 6/92 (6.5%) | |
No restenosis | 8/92 (8.7%) | |
Index stent interval in days | 1356.6 (±1477.4) | |
Index stent type | Biodegradable polymer-eluting stent | 5/92 (5.4%) |
Bare-metal stent | 4/92 (4.3%) | |
Biodegradable polymer sirolimus-eluting stent | 8/92 (8.7%) | |
Drug-eluting stent | 4/92 (4.3%) | |
Everolimus-eluting stent | 46/92 (50.0%) | |
Polymer-free sirolimus-eluting stent | 3/92 (3.3%) | |
Sirolimus-eluting stent | 3/92 (3.3%) | |
Zotarolimus-eluting stent | 3/92 (3.3%) | |
Unknown | 16/92 (17.4%) | |
Lesion length in mm | 11.5 (±6.2) | |
